Jianjie Ma, PhD, is Professor and Karl P. Klassen Chair of Thoracic Surgery in the Department of Surgery at The Ohio State University (OSU). He is an OSU Davis Heart Lung Research Institute Investigator and serves on the advisory committee of the Center for Regenerative Medicine and Cell Based Therapies in the College of Medicine.
Dr. Ma received his bachelor’s degree in Physics from Wuhan University in China, and came to the United States through the CUSPEA (China-US Physics Examination Application) program after his undergraduate education. He was chosen to represent the Department of Physiology and Biophysics at the Graduate Student Symposium of Baylor College of Medicine, where he received his PhD in 1989. Dr. Ma went on to become an Instructor of Physiology at Rush Medical College (1989-1991). He started his academic career as an Assistant Professor the Department of Physiology and Biophysics at Case Western Reserve University in 1992, and became a tenured Associate Professor in 1997. In 2001, he was recruited to the Robert Wood Johnson Medical School (RWJMS) as a University-named Professor.
During his time at UMDNJ, Dr. Ma founded the Graduate Program in Physiology and Integrative Biology, which is jointly sponsored by RWJMS and Rutgers University. He served on the Scientific Advisory Board for the Cancer Institute of New Jersey. He was acting chair of the Department of Physiology and Biophysics, as well as Chief of the Division of Developmental Medicine and Research. Dr. Ma serves on several National Institutes of Health study sections and various editorial boards. In addition to his faculty appointment with RWJMS, Dr. Ma founded TRIM-edicine, Inc., a university spinoff biotechnology company. TRIM-edicine develops novel biopharmaceutical products for the treatment of several important unmet medical needs. One specific therapeutic protein is MG53, which targets diseases involved chronic and acute tissue damage.
In 2012, Dr. Ma was recruited to The Ohio State University. His current research focuses are in muscle physiology, aging, cardiovascular disease, apoptosis, cancer biology, regenerative and translational medicine. He has authored more than 200 publications in high impact journals such as Nature, Science, Science Translational Medicine, Nature Cell Biology, Journal of Cell Biology, Circulation. He has assembled an international team of collaborators working on translational research. His group maintains close collaboration with pharmaceutical industries for joint development efforts toward translating basic discovery into clinical application.
Dr. Ma has trained numerous graduate and postgraduate students, and many of them have become leaders in academia, industry, medicine and law firms. He is an outstanding mentor and educator, and has coordinated the teaching of both medical and graduate students at university. He is also actively involved in teaching and collaboration with the Chinese Academy of Sciences and universities in China.